USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Gfbiochemicals Limited

USPTO PatentsView assignee record - 11 granted patents across 15 technology areas, active 2016–2019. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C08K (Use of inorganic or non-macromolecular organic substances as compounding ingredients).

11
Total patents granted
15
CPC technology areas
20.0
Avg claims per patent
-100%
5-year filing velocity

The verdict

Gfbiochemicals holds 11 US patents across 15 technology areas, rank #24,379 of 50,000 tracked assignees.

#24,379
of 50,000 US assignees by volume
Top 53%
by Innovation Score (34.3/100)
20.0
avg claims per patent
-100%
filing velocity, last 5 yrs

Portfolio overview

Gfbiochemicals Limited has been granted 11 US utility patents between 2016 and 2019, placing Gfbiochemicals Limited at rank #24,379 across all assignees tracked by PlainPatent. This portfolio spans 15 distinct Cooperative Patent Classification (CPC) subclasses, averaging 20.0 claims per patent with primary concentration in C08K (Use of inorganic or non-macromolecular organic substances as compounding ingredients). As a Foreign Corporation, Gfbiochemicals Limited is one of the more focused assignees in the PatentsView dataset. By volume, Gfbiochemicals sits between GE Oil & Gas, Inc. (11 patents, rank #24,375) and GO NET Systems Ltd (11 patents, rank #24,383) - the closest US assignees by grant volume. The composite Innovation Score of 34.3/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 0 grants, compared with 11 in the 2015–2019 window, a -100% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Gfbiochemicals Limited's 20.0 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 15 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Gfbiochemicals Limited against peers pursuing similar technology classes.

Who files at Gfbiochemicals's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Gfbiochemicals holds 11 patents at rank #24,379, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Gfbiochemicals's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

34 Top 53% higher than 47% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). This entry sits in this band. 40–50: 11,491 US assignees (23%). Above this entry. 50–60: 5,058 US assignees (10%). Above this entry. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

02468 2016201720182019 1
USPTO utility patent grants by year · 2016–2019

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table
Gfbiochemicals Limited patent grants by year, 2015–2025
Year Patents Granted Share of Period
2016 2 18.2%
2017 6 54.5%
2018 2 18.2%
2019 1 9.1%

Which technologies does Gfbiochemicals Limited patent most?

Top 15 of 15 technology areas

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Focused
Claim Depth Complex
Velocity Declining

Where it ranks

Overall rank by patents

#24,379

Across all tracked assignees

Innovation Score

34.3 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Gfbiochemicals Limited hold?
Gfbiochemicals Limited holds 11 US granted patents filed between 2016 and 2019, spanning 15 technology areas.
What is Gfbiochemicals Limited's Innovation Score?
Gfbiochemicals Limited has an Innovation Score of 34.3 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Gfbiochemicals Limited focus on?
Gfbiochemicals Limited's top technology area is C08K (Use of inorganic or non-macromolecular organic substances as compounding ingredients) with 6 patents. The company has filed patents in 15 CPC subclasses total.
Is Gfbiochemicals Limited's patent filing rate increasing or decreasing?
Gfbiochemicals Limited's recent filing velocity is -100% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for Gfbiochemicals Limited's patents?
Gfbiochemicals Limited's patents average 20.0 claims each. This indicates complex, broadly scoped patents that are harder for competitors to design around.
How is the Gfbiochemicals Limited patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Gfbiochemicals's 11 grants land it in the top 53% by Innovation Score, but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance - Gfbiochemicals ranks #24,379 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in C08K - see who else leads that technology area. C08K leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.